OCCIDENT

Pléiade Venture est une Société de Capital Risque Française. Elle investit sur le long terme, sans horizon de sortie prédéterminé. Elle soutient les entreprises innovantes de tous secteurs, hors biotech. Elle dispose de plus de 100 M€ d'actifs et investit de 0,5 à 3 M€ par opération. Elle est financée par des entrepreneurs qui forts de leur expérience désirent contribuer activement à de nouveaux succès. Elle est animée par une équipe en liaison étroite avec une vingtaine d’entrepreneurs contributifs. Nos différencesEvergreen: Pléiade Venture, à la différence des fonds, investit ses fonds propres et réinvestit ses plus-values, sans horizon de sortie prédéterminé. Actionnaire stable et pérenne, Pléiade Venture s’adapte au projet long terme de l’entrepreneur. Contributif: Notre capital est constitué d'entrepreneurs issus de secteurs variés. Ils réinvestissent une partie de leur patrimoine et partagent leur expérience avec les dirigeants de nos participations. Un quart de nos actionnaires sont d’ailleurs les fondateurs d'entreprises que nous avons financées. Galaxie: Pléiade Venture s’inscrit dans un ensemble de structures indépendantes : Pléiade Investissement (Capital Développement, LBO et retournement) Pléiade AM (Fonds d'actions cotées) autour d’une idée commune : « Faire ensemble, et faire autrement, ce que nous ne ferions pas seuls ! ». Nos CritèresStade: Seed, Series A Secteurs: Tous sauf : Biotechnologies, Entertainment, Immobilier Montant: 0,5 M€ à 3 M€, Seul ou en coinvestissement

Lingotto’s Innovation Fund is a new $600mm+ AUM crossover (public & private) fund focused on making concentrated and long-term investments in companies operating at the cutting edge of technological and business-model innovation. Core to our investment thesis is the fact that market returns are dominated by extreme structural winners – we seek to identify decades-long secular trends and the management teams best positioned to capitalize on them in the early years. The senior team has a notable history of private investments including: OpenAI, SpaceX, Alibaba, Coupang, Stripe, Databricks, Spotify, Airbnb, Tempus, Recursion, Ginkgo Bioworks, Palantir, Epic Games, Joby Aviation, Indigo, Aira, Humane, H2 Green Steel. The Innovation Fund is co-managed by James Anderson (CIO & Managing Partner) and Morgan Samet (Co-Head & Managing Partner). James has over 40 years of investment experience – most recently as a Partner at Baillie Gifford, where he managed over £100bn in AUM throughout his tenure. As head of the firm’s flagship fund, the Scottish Mortgage Investment Trust, he delivered a +1,555% return vs. +354% for the FTSE all-world benchmark (between April 2000 and March 2022). He was instrumental in the firm’s move into private investing starting with Alibaba in 2012. Morgan has over 19 years of experience in private and public market investing. She has previously worked at Belfer Management, Pzena Investment Management, Thomas H. Lee Partners, and Goldman Sachs. She received her MBA from Harvard Business School. The Innovation Fund is a part of Lingotto, a $4.5bn+ investment management company supported with permanent capital from Exor and additional external LPs. Exor is one of Europe’s largest publicly traded holding companies. Its assets include companies like Stellantis (Fiat, Chrysler, Citroen), Ferrari, Philips, Juventus Football Club, the Economist and Christian Louboutin. Exor’s CEO is John Elkann (Chairman of Ferrari); its Chairman is Nitin Nohria (Executive Chairman of Thrive Capital and former Dean of Harvard Business School). Lingotto’s Chairman is George Osborne, former UK chancellor.

LiquidMetal Ventures is a newly established venture capital fund based in Boston, aiming at investing in early-stage (Seed, Angel, and pre-A round) in a minority group, particularly deep-tech startups. LiquidMetal Ventures is based on deep-tech start-up communities and has a unique advantage in reaching out to ‘off-the-market’ early-stage deals and cooperating with peer VC funds tightly to reduce the risk, overall a high return could be expected. LiquidMetal Ventures focuses on biotech and healthcare, carbon neutrality, AI and data, infrastructure, and consumer tech. There is a huge tide of startups among Boston entrepreneurs in the US on the way. We would like to be the first to check VC with the founders. Investment FocusBioTech Medical Device Sustainability AI & Data Science Advanced Energy Technology Robotics & Advanced Manufacturing

We invest in opportunities backed by deep science. Xora is an early-stage investment platform of Temasek. We typically invest as a lead or co-lead investor in the Seed and Series A rounds, and later rounds (via our parent company). While we are not limited by geography, we prioritize opportunities that possess a strong linkage with the Singapore science & technology ecosystem. Leveraging the Temasek global network of investors and operating companies, we are active partners to ambitious founders building the next generation of impactful, world-changing companies. Our Team Our team possesses strong technical domain expertise in both physical and life sciences, and the intersection thereof, and are steeped in the nuances of early-stage deep science investing and venture building. We are global citizens with business experience in major markets. Our principles guide our engagement process and our investment decisions.We start with the people on the journey and a shared vision of the future. ​ We look for dogged persistence, unbounded creativity, acute self-awareness, a sense of urgency, and a passion for impact. We embrace both the technical and people complexity of science-based opportunities. ​ We welcome early and frequent contact and appreciate the opportunity to inform an emerging narrative. ​ We prefer brainstorming to pitches, and relationships to transactions. ​ We commit more than capital; we pledge our mindshare and our network.

The world has hard problems to solve, and answers are urgently needed. We help entrepreneurs on a mission to solve these hard problems build companies. We believe Singapore has the resources and capabilities to tackle the pressing challenges impacting people around the world. SGInnovate has been established to help these ambitious and capable people to build 'technology-intensive' products borne out of scientific research, leveraging the full power of the Singapore ecosystem to achieve this mission. Investment Capital Singapore has over $1b+ of private-market funds and another $1b+ of public-sector funds. Government Singapore remains one of the most attractive and trusted places to build companies, in large part due to our economic competitiveness, as well as political and operational stability. Research A global research and innovation hub, S$25B has been committed to Singapore's latest Research, Innovation and Enterprise (RIE) five-year plan, covering domains such as healthcare, sustainability and manufacturing, through to 2025. Corporate Backing Singapore brings together over 7000 regional and global corporations who represent go-to-market help, joint product development, investment funding and possible exits. World Class Institute of Higher Learning Singapore is home to two of the top 20 globally-ranked universities.

CDL has designed a new approach to enterprising research and innovation, nurturing an entrepreneurial mindset through expert opinion, funding opportunities, research analysis, and business development support. CDL’s objective-setting process enhances the performance of technical founders who learn from the insights of experienced entrepreneurs, increasing their probability of success. The Program involves:Mentorship from select entrepreneurs and angel investors: the Fellows and Associates Intensive full-day sessions with the CDL Mentors take place every eight weeks with the purpose of assessing progress and setting new short-term objectives. Fellows and Associates provide professional judgment (entrepreneurial knowledge) to help guide CDL Ventures and prioritize actions. The program is designed for early-stage, science-based technology companies, though we consider all applicants based on their potential to scale and the viability of their product. CDL’s objective-setting process enhances the performance of technical founders who learn from the insights of experienced entrepreneurs, increasing their probability of success. Opportunities to raise capital CDL Mentors are made up of a carefully selected group of exited entrepreneurs, angel investors, and partners from leading venture capital firms. These participants often invest in ventures that demonstrate a track record of achieving their objectives. Advice on technology roadmaps from CDL’s Chief Scientists World-renowned experts from leading academic institutions provide technical feedback to founders and advise the Fellows and Associates on objectives related to technology validation. Business development support from top students Business school students work to support ventures including developing financial models, evaluating potential markets, and fine-tuning strategies for scaling. Twelve locations globally CDL operates five sites in Canada, three in the United States and four in Europe. Launched in 2012 at the Rotman School of Management at University of Toronto, the program has now expanded with locations in Oxford (Saïd Business School, University of Oxford), Paris (HEC Paris), Atlanta (Scheller College of Business, Georgia Institute of Technology), Madison (Wisconsin School of Business, University of Wisconsin-Madison), Seattle (University of Washington, Foster School of Business), Berlin (European School of Management and Technology), Tartu (Delta Management School, University of Tartu), Vancouver (Sauder School of Business, University of British Columbia), Montreal (HEC Montréal), Calgary (Haskayne School of Business, University of Calgary), and Halifax (Rowe School of Business, Dalhousie University).